‘Fusion genes’ drive formation and growth of colorectal cancer

Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Weill Cornell Medicine investigators.

Researchers survey strategies to improve end of life quality

A new study draws on experiences of members of care teams working with end-of-life patients to identify strategies to improve quality of life through policies, palliative care practices and design.

Missing link identified between immune cells and Alzheimer’s

By studying the effects of immune cells that surround blood vessels in the brain, Weill Cornell Medicine researchers have discovered a new pathway that may contribute to Alzheimer’s disease.

Cornell's vegan Jack'd Jerky wins national food contest

Cornell’s Jack'd Jerky – a nutritious vegan snack that offers a refreshing respite from salt-laden meat jerky – won the 2017 IFT food product development competition June 27 in Las Vegas.

Brain's network may provide insights into neurological disorders

A deeper understanding of the brain’s connectivity network of neurons and its relationship to the organ’s deep tissue could allow recognition of what processes relate to neurological disorders.

New device could make closing surgical incisions a cinch

A material strong enough to protect the intestines from a needle puncture and bendable enough to insert through a laparotomy incision that quickly dissolves in the body is being studied.

Enzyme key to triggering anti-cancer immune response

An enzyme implicated in autoimmune diseases and viral infections also regulates radiation therapy's ability to trigger an immune response against cancer, Weill Cornell Medicine scientists found in a new study.

Cornell to team with IBM to protect global milk supply

Cornell and IBM announced a joint research project June 23 that will use genetic sequencing and big-data analyses to help keep the global milk supply safe.

Human tissue model developed to test colon cancer drugs

The first-ever 'disease in a Petri dish' platform that models human colon cancer derived from stem cells has been developed by Weill Cornell Medicine investigators, allowing them to identify a targeted drug treatment for a common, inherited form of the disease.